MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma

SIMPLE SUMMARY: In recent years, treatments enhancing the antitumor immune response have revealed a new promising approach for advanced hepatocellular carcinoma (HCC). Beside favorable results in about one third of patients, much still remains to be done to face primary nonresponse, early, and late...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramantieri, Laura, Fornari, Francesca, Giovannini, Catia, Trerè, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313100/
https://www.ncbi.nlm.nih.gov/pubmed/35883486
http://dx.doi.org/10.3390/biom12070930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313100/
https://www.ncbi.nlm.nih.gov/pubmed/35883486
http://dx.doi.org/10.3390/biom12070930

Ejemplares similares